Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland
International Journal of Pharmacy Practice · 13.07.2026
DOI: 10.1093/ijpp/riag090 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 13.07.2026. Verfasst von Jenny Demmel und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin D02 VN51, Ireland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
To assess the experiences and perspectives of community pharmacists in Ireland on Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity management.
Methods
An online questionnaire of closed- and open-ended questions was distributed to community pharmacists in the Republic of Ireland in July 2025. Closed-ended questions were analyzed quantitatively using descriptive statistics, and conventional content analysis was utilized for open-ended responses. Key findings Two hundred questionnaires were available for analysis. Respondents dispensed GLP-1 RAs for obesity (n = 31, 16.1%), and for both obesity and diabetes management (n = 160, 82.9%). Respondents frequently provided counselling on the practical aspects of GLP-1 RA use including storage (n = 162, 83.94%), administration (n = 143, 74.09%), side effects (n = 128, 66.32%), and sharps disposal (n = 99, 51.3%). However, topics such as nutrition and contraception were discussed less frequently, with 45.6% (n = 88) never providing contraception advice to female patients. Time constraints were the main barriers reported to counselling. Several challenges and concerns were highlighted by pharmacists including the impact of medication shortages on practice, increased pressure on pharmacy workflows, safety and prescribing oversight, particularly for online prescribing, alongside a need for additional education and training.
Conclusions
Community pharmacists in Ireland play a key role in dispensing GLP-1 RAs and providing patient support. They report gaps in counselling, training, professional guidance, and structural support, alongside safety concerns of online prescribing. Updated professional guidance, pharmacy-based practice models, and national policies will allow community pharmacists to better support the delivery of obesity care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin D02 VN51, Ireland.
- School of Population Health, Royal College of Surgeons in Ireland, Dublin D02 X0N1, Ireland.
- Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin D04 V1W8, Ireland.
ORCID-Profile: Ciara Farrell, Claire M Timon, Carel W le Roux, Angela C Flynn
Zitieren
APA
Demmel, J., Farrell, C., Timon, C. M., Cleary, O., Christie, H. L., O'Leary, N., George, C. V., Dunne, P., Mitchell, S., le Roux, C. W., O'Hara, C., Flood, M., & Flynn, A. C. (2026). Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag090
Vancouver
Demmel J, Farrell C, Timon CM, Cleary O, Christie HL, O'Leary N, et al. Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag090
BibTeX
@article{Demmel2026,
author = {Demmel, Jenny and Farrell, Ciara and Timon, Claire M and Cleary, Olga and Christie, Hannah L and O'Leary, Noreen and George, Catherine V and Dunne, Pauline and Mitchell, Sheena and le Roux, Carel W and O'Hara, Cathal and Flood, Michelle and Flynn, Angela C},
title = {Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland},
journal = {International Journal of Pharmacy Practice},
year = {2026},
doi = {10.1093/ijpp/riag090}
}
EUVIMED